Page last updated: 2024-08-21

indazoles and Nephrotic Syndrome

indazoles has been researched along with Nephrotic Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasebe, N; Kabara, M; Maruyama, K; Matsuki, M; Nakagawa, N; Ogawa, Y; Shindo, M; Suzuki, A	1
Jeon, SY; Lee, NR; Yim, CY	1
Maltezou, M; Miaris, N; Papaxoinis, G; Samantas, E; Visvikis, A	1

Reviews

1 review(s) available for indazoles and Nephrotic Syndrome

Article	Year
Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Axitinib; Carcinoma, Renal Cell; Everolimus; Fatal Outcome; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides	2017

Article

Year

Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.

Clinical genitourinary cancer, 2017, Volume: 15, Issue:1

Topics: Axitinib; Carcinoma, Renal Cell; Everolimus; Fatal Outcome; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Posterior Leukoencephalopathy Syndrome; Pyrimidines; Sulfonamides

2017

Other Studies

2 other study(ies) available for indazoles and Nephrotic Syndrome

Article	Year
Pazopanib-induced Endothelial Injury with Podocyte Changes. Internal medicine (Tokyo, Japan), 2018, Apr-01, Volume: 57, Issue:7 Topics: Adult; Humans; Indazoles; Male; Nephrotic Syndrome; Podocytes; Proteinuria; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma; Sulfonamides	2018
Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report. BMC nephrology, 2019, 01-03, Volume: 20, Issue:1 Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diabetic Nephropathies; Dihydropyridines; Drug Substitution; Edema; Everolimus; Humans; Hypertension; Indazoles; Kidney Failure, Chronic; Lung Neoplasms; Male; Nephrotic Syndrome; Nivolumab; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrimidines; Sirolimus; Sulfonamides; Sunitinib	2019

Article

Year

Pazopanib-induced Endothelial Injury with Podocyte Changes.

Internal medicine (Tokyo, Japan), 2018, Apr-01, Volume: 57, Issue:7

Topics: Adult; Humans; Indazoles; Male; Nephrotic Syndrome; Podocytes; Proteinuria; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma; Sulfonamides

2018

Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.

BMC nephrology, 2019, 01-03, Volume: 20, Issue:1

Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diabetic Nephropathies; Dihydropyridines; Drug Substitution; Edema; Everolimus; Humans; Hypertension; Indazoles; Kidney Failure, Chronic; Lung Neoplasms; Male; Nephrotic Syndrome; Nivolumab; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrimidines; Sirolimus; Sulfonamides; Sunitinib

2019